HCPCS J1626

Injection, granisetron hydrochloride, 100 mcg

HCPCS Information

HCPCS Code: J1626
The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J1626 identifies the type of service or supply used while any of the 11 NDC codes below could be used to specify the exact drug used.
Short Description
Granisetron hcl injection
Long Description
Injection, granisetron hydrochloride, 100 mcg
Pricing Indicator
Drugs
Multiple Pricing Indicator
Not applicable as HCPCS priced under one methodology
Coverage Description
Special coverage instructions apply
BETOS Type of Service
Other drugs
Medicare Payment Limit
$0.15
Medicare Co-Insurance Percentage
20.000%
HCPCS Classification
List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)

HCPCS Crossover to NDC Codes

The NDC codes below allow precise billing based on the specific manufacturer and medication used:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0143-9744Granisetron Hydrochloride Granisetron HydrochlorideInjectionIntravenousHikma Pharmaceuticals Usa Inc.ACTIVE
0143-9745Granisetron Hydrochloride Granisetron HydrochlorideInjectionIntravenousHikma Pharmaceuticals Usa Inc.ACTIVE
63323-318Granisetron Granisetron HydrochlorideInjection, SolutionIntravenousFresenius Kabi Usa, LlcACTIVE
63323-319Granisetron Fresenius Kabi Usa, Llc
64679-661Granisetron Hydrochloride Wockhardt Usa Llc.
64679-661Granisetron Hydrochloride Wockhardt Usa Llc.
64679-662Granisetron Hydrochloride Wockhardt Usa Llc.
66758-035Granisetron Sandoz Inc.
66758-036Granisetron Sandoz Inc.
67457-863Granisetron Hydrochloride Granisetron HydrochlorideInjection, SolutionIntravenousMylan Institutional LlcACTIVE
67457-864Granisetron Hydrochloride Granisetron HydrochlorideInjection, SolutionIntravenousMylan Institutional LlcACTIVE